Anticancer Drugs Course
This Anticancer Drugs Course equips oncology professionals with practical knowledge on first-line EGFR TKI strategies for EGFR-mutated NSCLC. Participants learn to manage toxicities effectively, handle resistance challenges, optimise patient outcomes, and communicate treatment plans clearly using evidence-based approaches.

from 4 to 360h flexible workload
valid certificate in your country
What will I learn?
Gain a practical overview of first-line systemic treatments for EGFR-mutated NSCLC, covering targeted therapies, chemo-immunotherapy, and chemotherapy. Master drug mechanisms, dosing schedules, toxicity management, resistance mechanisms, second-line therapies, monitoring protocols, and patient communication skills for evidence-based decisions.
Elevify advantages
Develop skills
- Select optimal EGFR TKI first-line treatments based on latest clinical trial data.
- Plan resistance assessments including imaging, re-biopsy, and liquid biopsy for therapy guidance.
- Develop second-line plans matching resistance to targeted therapy, chemo, or trials.
- Prevent and manage key toxicities like EGFR TKI rash, diarrhoea, ILD, and cytopenias.
- Counsel patients clearly on treatment goals, side effects, and progression management.
Suggested summary
Before starting, you can change the chapters and workload. Choose which chapter to start with. Add or remove chapters. Increase or decrease the course workload.What our students say
FAQs
Who is Elevify? How does it work?
Do the courses have certificates?
Are the courses free?
What is the course workload?
What are the courses like?
How do the courses work?
What is the duration of the courses?
What is the cost or price of the courses?
What is an EAD or online course and how does it work?
PDF Course